MacroGenics, Inc. (MGNX)
4.06
+0.32
(+8.56%)
USD |
NASDAQ |
Sep 28, 16:00
4.06
0.00 (0.00%)
After-Hours: 19:03
MacroGenics Cash from Operations (Annual) : -81.04M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -81.04M |
| December 31, 2024 | -68.37M |
| December 31, 2023 | -78.20M |
| December 31, 2022 | -86.96M |
| December 31, 2021 | -143.83M |
| December 31, 2020 | -111.90M |
| December 31, 2019 | -134.27M |
| December 31, 2018 | -153.23M |
| Date | Value |
|---|---|
| December 31, 2017 | 14.40M |
| December 31, 2016 | -43.68M |
| December 31, 2015 | -13.66M |
| December 31, 2014 | -32.86M |
| December 31, 2013 | -14.17M |
| December 31, 2012 | -6.582M |
| December 31, 2011 | 6.757M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Gilead Sciences, Inc. | 10.02B |
| Xencor, Inc. | -135.12M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |